RO6811135

DRUG4 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetes Mellitus Type 2Healthy Volunteer

Phase 1

A Study of Single Dose RO6811135 in Healthy Volunteers

CompletedNCT01676584

Hoffmann-La RocheHealthy Volunteer

Start: 2012-09-30End: 2012-12-31Updated: 2016-11-02

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus

CompletedNCT01789788

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2013-03-31End: 2013-09-30Updated: 2016-11-02

A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers

CompletedNCT01802853

Hoffmann-La RocheHealthy Volunteer

Start: 2013-05-31End: 2013-06-30Updated: 2016-11-02

Phase 2

A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin

WithdrawnNCT01951183

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2013-12-31End: 2013-12-31Updated: 2016-11-02